Stent maker Tryton Medical closed a $24 million financing round with funds expected to help get the company through FDA approval of its Tryton Side Branch Stent.

Medical device maker Tryton Medical today announced that it closed a $24 million equity funding round designed to get the company through FDA approval for its Tryton Side Branch Stent.

All of Tryton's existing investors participated in the latest financing round, with leading funds coming from PTV Sciences, according to a press release.